HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Prevention of vascular complications after cerebral ischemia of arterial origin. European Stroke and Australian Stroke Prevention in Reversible Ischemia Trial (ESPRIT): moderated coagulation, aspirin-dipyridamole combination or aspirin alone?].

AuthorsE L De Schryver, J W Gorter, A Algra, J van Gijn
JournalLa Revue de medecine interne (Rev Med Interne) Vol. 20 Issue 5 Pg. 397-9 (May 1999) ISSN: 0248-8663 [Print] France
Vernacular TitlePrévention des complications vasculaires après ischémie cérébrale d'origine artérielle. Etude ESPRIT: anticoagulation modérée, association aspirine-dipyridamole ou aspirine seule?
PMID10365408 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents
  • Dipyridamole
  • Aspirin
Topics
  • Anticoagulants (therapeutic use)
  • Aspirin (therapeutic use)
  • Cerebrovascular Disorders (prevention & control)
  • Dipyridamole (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Ischemic Attack, Transient (drug therapy)
  • Platelet Aggregation Inhibitors
  • Vasodilator Agents (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: